Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction

Wan Namkung, Zhen Yao, Walter E. Finkbeiner, A. S. Verkman

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

TMEM16A (ANO1) is a calcium-activated chloride channel (CaCC) expressed in secretory epithelia, smooth muscle, and other tissues. Cell-based functional screening of ∼110,000 compounds revealed compounds that activated TMEM16A CaCC conductance without increasing cytoplasmic Ca 2+. By patch-clamp, N-aroylaminothiazole "activators" (E act) strongly increased Cl - current at 0 Ca 2+, whereas tetrazolylbenzamide "potentiators" (F act) were not active at 0 Ca 2+ but reduced the EC 50 for Ca 2+- dependent TMEM16A activation. Of 682 analogs tested, the most potent activator (E act) and potentiator (F act) produced large and more sustained CaCC Cl -currents than general agonists of Ca 2+ signaling, with EC 50 3-6 μM and Cl - conductance comparable to that induced transiently by Ca 2+-elevating purinergic agonists. Analogs of activators were identified that fully inhibited TMEM16A Cl - conductance, providing further evidence for direct TMEM16A binding. The TMEM16A activators increased CaCC conductance in human salivary and airway submucosal gland epithelial cells, and IL-4 treated bronchial cells, and stimulated submucosal gland secretion in human bronchi and smooth muscle contraction in mouse intestine. Small-molecule, TMEM16A-targeted activators may be useful for drug therapy of cystic fibrosis, dry mouth, and gastrointestinal hypomotility disorders, and for pharmacological dissection of TMEM16A function.

Original languageEnglish
Pages (from-to)4048-4062
Number of pages15
JournalFASEB Journal
Volume25
Issue number11
DOIs
Publication statusPublished - 2011 Nov 1

Fingerprint

Intestinal Secretions
Chloride Channels
Chlorides
Molecules
Smooth Muscle
Muscle
Purinergic Agonists
Drug therapy
Dissection
Clamping devices
Bronchi
Muscle Contraction
Cystic Fibrosis
Interleukin-4
Intestines
Mouth
Screening
Epithelium
Epithelial Cells
Chemical activation

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

@article{cf6df0d246de48018d5ced296fa06594,
title = "Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction",
abstract = "TMEM16A (ANO1) is a calcium-activated chloride channel (CaCC) expressed in secretory epithelia, smooth muscle, and other tissues. Cell-based functional screening of ∼110,000 compounds revealed compounds that activated TMEM16A CaCC conductance without increasing cytoplasmic Ca 2+. By patch-clamp, N-aroylaminothiazole {"}activators{"} (E act) strongly increased Cl - current at 0 Ca 2+, whereas tetrazolylbenzamide {"}potentiators{"} (F act) were not active at 0 Ca 2+ but reduced the EC 50 for Ca 2+- dependent TMEM16A activation. Of 682 analogs tested, the most potent activator (E act) and potentiator (F act) produced large and more sustained CaCC Cl -currents than general agonists of Ca 2+ signaling, with EC 50 3-6 μM and Cl - conductance comparable to that induced transiently by Ca 2+-elevating purinergic agonists. Analogs of activators were identified that fully inhibited TMEM16A Cl - conductance, providing further evidence for direct TMEM16A binding. The TMEM16A activators increased CaCC conductance in human salivary and airway submucosal gland epithelial cells, and IL-4 treated bronchial cells, and stimulated submucosal gland secretion in human bronchi and smooth muscle contraction in mouse intestine. Small-molecule, TMEM16A-targeted activators may be useful for drug therapy of cystic fibrosis, dry mouth, and gastrointestinal hypomotility disorders, and for pharmacological dissection of TMEM16A function.",
author = "Wan Namkung and Zhen Yao and Finkbeiner, {Walter E.} and Verkman, {A. S.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1096/fj.11-191627",
language = "English",
volume = "25",
pages = "4048--4062",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "11",

}

Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction. / Namkung, Wan; Yao, Zhen; Finkbeiner, Walter E.; Verkman, A. S.

In: FASEB Journal, Vol. 25, No. 11, 01.11.2011, p. 4048-4062.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction

AU - Namkung, Wan

AU - Yao, Zhen

AU - Finkbeiner, Walter E.

AU - Verkman, A. S.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - TMEM16A (ANO1) is a calcium-activated chloride channel (CaCC) expressed in secretory epithelia, smooth muscle, and other tissues. Cell-based functional screening of ∼110,000 compounds revealed compounds that activated TMEM16A CaCC conductance without increasing cytoplasmic Ca 2+. By patch-clamp, N-aroylaminothiazole "activators" (E act) strongly increased Cl - current at 0 Ca 2+, whereas tetrazolylbenzamide "potentiators" (F act) were not active at 0 Ca 2+ but reduced the EC 50 for Ca 2+- dependent TMEM16A activation. Of 682 analogs tested, the most potent activator (E act) and potentiator (F act) produced large and more sustained CaCC Cl -currents than general agonists of Ca 2+ signaling, with EC 50 3-6 μM and Cl - conductance comparable to that induced transiently by Ca 2+-elevating purinergic agonists. Analogs of activators were identified that fully inhibited TMEM16A Cl - conductance, providing further evidence for direct TMEM16A binding. The TMEM16A activators increased CaCC conductance in human salivary and airway submucosal gland epithelial cells, and IL-4 treated bronchial cells, and stimulated submucosal gland secretion in human bronchi and smooth muscle contraction in mouse intestine. Small-molecule, TMEM16A-targeted activators may be useful for drug therapy of cystic fibrosis, dry mouth, and gastrointestinal hypomotility disorders, and for pharmacological dissection of TMEM16A function.

AB - TMEM16A (ANO1) is a calcium-activated chloride channel (CaCC) expressed in secretory epithelia, smooth muscle, and other tissues. Cell-based functional screening of ∼110,000 compounds revealed compounds that activated TMEM16A CaCC conductance without increasing cytoplasmic Ca 2+. By patch-clamp, N-aroylaminothiazole "activators" (E act) strongly increased Cl - current at 0 Ca 2+, whereas tetrazolylbenzamide "potentiators" (F act) were not active at 0 Ca 2+ but reduced the EC 50 for Ca 2+- dependent TMEM16A activation. Of 682 analogs tested, the most potent activator (E act) and potentiator (F act) produced large and more sustained CaCC Cl -currents than general agonists of Ca 2+ signaling, with EC 50 3-6 μM and Cl - conductance comparable to that induced transiently by Ca 2+-elevating purinergic agonists. Analogs of activators were identified that fully inhibited TMEM16A Cl - conductance, providing further evidence for direct TMEM16A binding. The TMEM16A activators increased CaCC conductance in human salivary and airway submucosal gland epithelial cells, and IL-4 treated bronchial cells, and stimulated submucosal gland secretion in human bronchi and smooth muscle contraction in mouse intestine. Small-molecule, TMEM16A-targeted activators may be useful for drug therapy of cystic fibrosis, dry mouth, and gastrointestinal hypomotility disorders, and for pharmacological dissection of TMEM16A function.

UR - http://www.scopus.com/inward/record.url?scp=80355129636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80355129636&partnerID=8YFLogxK

U2 - 10.1096/fj.11-191627

DO - 10.1096/fj.11-191627

M3 - Article

C2 - 21836025

AN - SCOPUS:80355129636

VL - 25

SP - 4048

EP - 4062

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 11

ER -